WallStreetZen

NASDAQ: GILD
Gilead Sciences Inc Stock Forecast, Predictions & Price Target

Analyst price target for GILD

Based on 14 analysts offering 12 month price targets for Gilead Sciences Inc.
Min Forecast
$61.00-5.99%
Avg Forecast
$76.93+18.55%
Max Forecast
$88.00+35.61%

Should I buy or sell GILD stock?

Buy
Strong Buy
5 analysts 26.32%
Buy
4 analysts 21.05%
Hold
8 analysts 42.11%
Sell
1 analysts 5.26%
Strong Sell
1 analysts 5.26%

GILD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDate
Louise Pearson
Redburn
Strong BuyUpgradesN/AN/A2021-03-30
Matthew Harrison
Morgan Stanley
Strong BuyMaintains$87.00+34.07%2021-02-05
Jason McCarthy
Maxim Group
Strong BuyUpgrades$88.00+35.61%2020-09-15
Tyler Van Buren
Piper Sandler
Strong BuyMaintains$83.00+27.91%2020-08-19
Alethia Young
Cantor Fitzgerald
Strong BuyMaintains$84.00+29.45%2020-08-19
Aaron Gal
Bernstein
BuyUpgrades$80.00+23.29%2021-04-01
Geoff Porges
SVB Leerink
BuyMaintains$72.00+10.96%2021-02-11
Geoffrey Porges
SVB Leerink
BuyMaintains$73.00+12.50%2021-02-05
Brian Abrahams
RBC Capital
BuyMaintains$86.00+32.53%2020-09-18
Evan Seigerman
Credit Suisse
HoldMaintains$66.00+1.71%2021-02-05

1 of 2

Forecast return on equity

Is GILD forecast to generate an efficient return?
Company
56.17%
Industry
76.5%
Market
31,779.91%
GILD's Return on Equity is forecast to be high in 3 years (56.17%); analysts are confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is GILD forecast to generate an efficient return on assets?
Company
14.95%
Industry
16.75%
Market
11,448.12%
GILD is forecast to generate lower Return on Assets (14.95%) than the US Drug Manufacturers - General industry average (16.75%)
Forecast

GILD earnings per share forecast

What is GILD's earnings per share in the next 3 years based on estimates from 13 analysts?
Avg 1 year Forecast
$7.21+7,106.2%
Avg 2 year Forecast
$7.14+7,041%
Avg 3 year Forecast
$7.41+7,310%
GILD's earnings are forecast to grow at an exceptional rate of 318.56% per year
Forecast

GILD revenue forecast

What is GILD's revenue in the next 3 years based on estimates from 9 analysts?
Avg 1 year Forecast
$24.9B+0.74%
Avg 2 year Forecast
$24.3B-1.46%
Avg 3 year Forecast
$24.8B+0.53%
GILD's revenue is forecast to grow at a rate of 0.17% per year, which is not exceptional
Forecast

GILD earnings growth forecast

How is GILD forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
318.56%
Industry
35.43%
Market
23.37%
GILD's earnings are forecast to grow faster (318.56% per year) than the US Drug Manufacturers - General industry average (35.43%)
Forecast
GILD's earnings are forecast to grow faster (318.56% per year) than the US market average (23.37%)
Forecast
GILD's earnings are forecast to grow faster (318.56% per year) than the risk-free savings rate (1.6%)
Forecast

GILD revenue growth forecast

How is GILD forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
0.17%
Industry
5.96%
Market
15.09%
GILD's revenues are forecast to grow slower (0.17% per year) than the US Drug Manufacturers - General industry average (5.96%)
Forecast
GILD's revenues are forecast to grow slower (0.17% per year) than the US market average (15.09%)
Forecast

Gilead Sciences Stock Forecast FAQ

Is Gilead Sciences Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 19 Wall Street analysts covering (NASDAQ: GILD) stock is to Buy GILD stock.

Out of 19 analysts, 5 (26.32%) are recommending GILD as a Strong Buy, 4 (21.05%) are recommending GILD as a Buy, 8 (42.11%) are recommending GILD as a Hold, 1 (5.26%) are recommending GILD as a Sell, and 1 (5.26%) are recommending GILD as a Strong Sell.

What is GILD's earnings growth forecast for 2021-2023?

(NASDAQ: GILD) Gilead Sciences's forecast annual earnings growth rate of 318.56% is forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 35.43%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 23.37%.

Gilead Sciences's earnings in 2021 is $123,000,000.On average, 13 Wall Street analysts forecast GILD's earnings for 2021 to be $9,033,174,547, with the lowest GILD earnings forecast at $8,649,344,228, and the highest GILD earnings forecast at $9,514,278,651. On average, 10 Wall Street analysts forecast GILD's earnings for 2022 to be $8,951,444,512, with the lowest GILD earnings forecast at $8,310,891,628, and the highest GILD earnings forecast at $9,464,137,525.

In 2023, GILD is forecast to generate $9,288,643,584 in earnings, with the lowest earnings forecast at $8,398,638,598 and the highest earnings forecast at $10,153,578,007.

What is GILD's revenue growth forecast for 2021-2023?

(NASDAQ: GILD) Gilead Sciences's forecast annual revenue growth rate of 0.17% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 5.96%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 15.09%.

Gilead Sciences's revenue in 2021 is $24,689,000,000.On average, 9 Wall Street analysts forecast GILD's revenue for 2021 to be $31,178,047,954,571, with the lowest GILD revenue forecast at $30,377,976,092,303, and the highest GILD revenue forecast at $32,236,983,407,833. On average, 9 Wall Street analysts forecast GILD's revenue for 2022 to be $30,497,042,463,536, with the lowest GILD revenue forecast at $28,061,844,666,677, and the highest GILD revenue forecast at $32,366,096,807,180.

In 2023, GILD is forecast to generate $31,110,876,395,179 in revenue, with the lowest revenue forecast at $28,023,073,041,029 and the highest revenue forecast at $33,958,077,556,410.

What is GILD's forecast return on assets (ROA) for 2021-2024?

(NASDAQ: GILD) forecast ROA is 14.95%, which is lower than the forecast US Drug Manufacturers - General industry average of 16.75%.

What is GILD's Price Target?

According to 14 Wall Street analysts that have issued a 1 year GILD price target, the average GILD price target is $76.93, with the highest GILD stock price forecast at $88.00 and the lowest GILD stock price forecast at $61.00.

On average, Wall Street analysts predict that Gilead Sciences's share price could stay at $76.93 by Apr 1, 2022. The average Gilead Sciences stock price prediction forecasts a potential downside of N/A from the current GILD share price of $64.89.

What is GILD's Earnings Per Share (EPS) forecast for 2021-2023?

(NASDAQ: GILD) Gilead Sciences's current Earnings Per Share (EPS) is $0.10. On average, analysts forecast that GILD's EPS will be $7.21 for 2021, with the lowest EPS forecast at $6.90, and the highest EPS forecast at $7.59. On average, analysts forecast that GILD's EPS will be $7.14 for 2022, with the lowest EPS forecast at $6.63, and the highest EPS forecast at $7.55. In 2023, GILD's EPS is forecast to hit $7.41 (min: $6.70, max: $8.10).

What is GILD's forecast return on equity (ROE) for 2021-2024?

(NASDAQ: GILD) forecast ROE is 56.17%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.